RAYTHEON CO's ticker is RTN and the CUSIP is 755111507. A total of 1,501 filers reported holding RAYTHEON CO in Q4 2019. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
About RAYTHEON CO
Raytheon Co. is a leading technology and innovation company that specializes in defense, civil government, and cybersecurity solutions. With a history spanning over 90 years, Raytheon has established itself as a trusted partner to governments and businesses around the world.
One of the key strengths of Raytheon is its focus on research and development. The company invests heavily in cutting-edge technologies and has a strong track record of delivering innovative solutions to its customers. This has helped Raytheon to stay ahead of the competition and maintain its position as a leader in the industry.
Another factor that sets Raytheon apart is its commitment to sustainability. The company has set ambitious goals to reduce its environmental impact and has implemented a number of initiatives to achieve these goals. This includes reducing greenhouse gas emissions, conserving water, and minimizing waste.
Despite the challenges posed by the COVID-19 pandemic, Raytheon has continued to perform well. The company reported strong financial results in the first quarter of 2021, with net sales of $15.2 billion and earnings per share of $0.90. This is a testament to the resilience of the company and its ability to adapt to changing market conditions.
Overall, Raytheon is a company that is well-positioned for long-term success. With its focus on innovation, sustainability, and strong financial performance, Raytheon is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,912,000 | -42.6% | 14,580 | -3.8% | 1.99% | -30.9% |
| Q4 2019 | $3,330,000 | +12.0% | 15,155 | 0.0% | 2.87% | +4.6% |
| Q3 2019 | $2,973,000 | +7.0% | 15,155 | -5.2% | 2.75% | +12.1% |
| Q2 2019 | $2,779,000 | -4.5% | 15,980 | 0.0% | 2.45% | -6.2% |
| Q1 2019 | $2,910,000 | +17.9% | 15,980 | -0.7% | 2.61% | +4.2% |
| Q4 2018 | $2,468,000 | -26.9% | 16,096 | -1.5% | 2.50% | -15.7% |
| Q3 2018 | $3,378,000 | +4.8% | 16,346 | -2.0% | 2.97% | +0.8% |
| Q2 2018 | $3,222,000 | -7.6% | 16,680 | +3.4% | 2.95% | -7.4% |
| Q1 2018 | $3,487,000 | +14.6% | 16,135 | -0.4% | 3.18% | +14.7% |
| Q4 2017 | $3,044,000 | – | 16,205 | – | 2.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brick & Kyle, Associates | 62,251 | $4,480 | 2.38% |
| Providence Wealth Advisors, LLC | 6,475 | $462,478 | 0.52% |
| PHYSICIANS FINANCIAL SERVICES, INC. | 14,579 | $1,049 | 0.43% |
| Shakespeare Wealth Management, LLC | 8,383 | $603,325 | 0.21% |